Kiwi researchers are working to close an equity gap in Maori and Pasifika women's healthcare

Genetic tests to determine a patient's compatibility with life-saving ovarian cancer drugs are currently designed for European women.

New tests developed by Auckland University researchers would ensure treatment plans can actually target the patient's cancer.

Researcher, Professor Andrew Shelling says it's exciting to have something like this being made here.

He says New Zealand needs to have something homemade, to address equity issues related to Maori and Pasifika women.